For the full year 2016, the Sartorius Group has reported total sales of €1.3bn ($1.4bn), with the company’s Bioprocess Solutions Division – described by the firm as “the growth engine in the reporting year yet again” – contributing €975m.
The division incorporates the firm’s portfolio of disposable upstream and downstream biomanufacturing equipment and consumables, and the 22.1% growth on 2015’s results refelects industry’s continued demand for single-use technologies.
“Our Bioprocess Solutions Division is continuing to expand strongly,” said CEO Joachim Kreuzburg.
“As a supplier for the biopharmaceutical industry, the division addresses a very dynamic market and is additionally gaining market share in the important North American market.”
While it was thought Europe had initially led the way in embracing single-use technologies, Sartorius reported in January 2015 that the US had caught up. Since then the firm has continued to report double-digit quarterly growth in the business unit.
According to the firm, 2016 sales were split geographically with the EMEA representing 44% of the firm’s revenues, while the Americas made up 34%, and Asia-Pacific represented 22%.